Pharmacological principles of intravitreal drug therapy and their implications for clinical practice: a primer for the ophthalmologist - Scorecard - MDSpire

Pharmacological principles of intravitreal drug therapy and their implications for clinical practice: a primer for the ophthalmologist

  • By

  • Samia Ezzine

  • Richard Gale

  • Clare Bailey

  • Praveen J. Patel

  • Sobha Sivaprasad

  • Zinab Keshk

  • Thomas Eissing

  • Joachim Höchel

  • Rose Gilbert

  • Peter Morgan-Warren

  • May 21, 2026

  • 0 min

Share

Clinical Scorecard: Fundamental Pharmacological Concepts of Intravitreal Drug Administration and Their Relevance in Clinical Ophthalmology: An Overview for Eye Care Professionals

At a Glance

CategoryDetail
ConditionNeovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO)
Key MechanismsInhibition of vascular endothelial growth factor (VEGF) and modulation of downstream cellular signaling pathways.
Target PopulationPatients with nAMD and DMO requiring intravitreal anti-VEGF therapy.
Care SettingOphthalmology clinics.

Key Highlights

  • IVT anti-VEGF therapies have improved outcomes compared to previous treatments.
  • Frequent injections can lead to treatment burden and patient anxiety.
  • Durability of treatment effects is crucial for maintaining vision improvements.
  • Pharmacological properties influence the duration of therapeutic effects.
  • Emerging therapies are exploring targets beyond VEGF.

Guideline-Based Recommendations

Diagnosis

  • Assess visual acuity and retinal imaging for nAMD and DMO.

Management

  • Utilize IVT anti-VEGF therapies as standard care for nAMD and DMO.

Monitoring & Follow-up

  • Regular follow-up to evaluate treatment efficacy and adjust intervals as needed.

Risks

  • Potential for vision loss if treatment intervals are extended too long.

Patient & Prescribing Data

Individuals diagnosed with nAMD or DMO.

Patients may require varying injection frequencies based on individual response.

Clinical Best Practices

  • Educate patients about the treatment process and potential side effects.
  • Consider patient-specific factors when determining treatment intervals.
  • Stay updated on emerging therapies and their pharmacological profiles.

Related Resources & Content

Original Source(s)

Related Content